27.01. | Hong Kong stocks ease ahead of China market reopening after Lunar New Year holiday |  |
26.01. | Hong Kong stocks hit 9-month high on lunar new year rush |  |
19.01. | Sino Biopharmaceutical to Redeem Bonds of 487.6 Million Euros |  |
19.01. | La actualización de la Lista Nacional de Medicamentos Reembolsables de China cumple las.. |  |
16.01. | Chinese Regulator Grants Marketing Approval to Akeso, Sino Biopharmaceutical's Lung Can.. |  |
13.01. | China Accepts Sino Biopharmaceutical's Marketing Application for Lung Cancer Drug |  |
13.01. | Sino Biopharmaceutical Limited Announces Application for Marketing of Category I Innova.. |  |
11.01. | Sino Biopharmaceutical Unit Gets Exclusive Commercialization Rights for Denosumab Injec.. |  |
03.01. | Sino Biopharmaceutical Unit to Exclusively Market PL-5 Peptide |  |
02.01. | Sino Biopharmaceutical Gets Marketing Rights to COVID-19 Drug Ensitrelvir |  |
2022 | Top Midday Gainers |  |
2022 | F-Star Therapeutics Shares Erase Much of Thursday's Loss |  |
2022 | F-star Therapeutics Extends invoX Deal Date to Help Address CFIUS Concerns; Shares Rise |  |
2022 | Boan Biotechnology Raises HK$152.8 Million in Hong Kong IPO |  |
2022 | Shandong Boan Biotechnology Seeks Up to HK$212 Million in Hong Kong IPO |  |
2022 | Sino Biopharmaceutical Completes Patient Enrollment in Anti-Haemophilia Drug Trial |  |
2022 | Sino Biopharmaceutical Limited Announces the Enrollment of All Patients in Phase III Cl.. |  |
2022 | Sector Update: Health Care Stocks Advance Modestly |  |
2022 | Sino Biopharmaceutical's Q3 Revenue Rises 21%; Shares Rise 5% |  |
2022 | Sino Biopharmaceutical Limited Provides Revenue Guidance for 2023 |  |
2022 | Sino Biopharmaceutical Limited Reports Unaudited Revenue Results for the Third Quarter .. |  |
2022 | Sino Biopharmaceutical Limited Announces Resignation of Wang Shanchun as Executive Dire.. |  |
2022 | Trustee Purchases Sino Biopharmaceutical Shares for $1.3 Million |  |
2022 | Trustee Purchases 2,780,000 Sino Biopharmaceutical Shares for $1.3 Million |  |
2022 | Chinese Regulator Approves Clinical Trial of Sino Biopharmaceutical's COVID-19 Medicine.. |  |
2022 | Inventiva ADRs Rise 22% After Licensing Deal With Chia Tai-Tianqing Pharma |  |
2022 | Chia Tai-Tianqing Signs Agreement for Lanifibranor |  |
2022 | Sino Biopharmaceutical Trustee Purchases Shares for $1 Million |  |
2022 | Sino Biopharmaceutical Trustee Purchases Additional $1 Million Shares |  |
2022 | HanchorBio Inc. announced that it has received $10 million in funding from Zero2IPO Ven.. |  |
2022 | Sino Biopharmaceutical Limited announces an Equity Buyback for 1,882,009,423 shares, re.. |  |
2022 | China's CanSinoBIO H1 revenue drops on weaker COVID shot demand |  |
2022 | Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to .. |  |
2022 | Sino Biopharmaceutical Limited Announces Interim Cash Dividend for the period ended 30 .. |  |
2022 | Sino Biopharmaceutical Limited Reports Earnings Results for the Half Year Ended June 30.. |  |
2022 | Hong Kong Hang Seng Up 0.5% As Property and Tech Sectors Edge Higher |  |
2022 | Sino Biopharmaceutical CEO Resigns |  |
2022 | Sino Biopharmaceutical Limited Announces Resignation of Li Yi as Executive Director |  |
2022 | Sino Biopharmaceutical Limited Announces CEO Changes, Effective July 28, 2022 |  |
2022 | Generon Corporation Ltd. announced that it has received $70.000203 million in funding f.. |  |
2022 | Hong Kong Hang Seng Down 0.6% As Tech Issues Weaken |  |
2022 | Sino Biopharmaceutical Submits Application for Marketing of Anti-Tumor Capsule |  |
2022 | Sino Biopharmaceutical Limited Announces Application for Marketing of Category 1 Anti-T.. |  |
2022 | Sino Biopharmaceutical to Buy Nasdaq-listed F-Star Therapeutics for $161 Million; Share.. |  |
2022 | Sector Update: Health Care Stocks Lead Thursday Markets Recovery |  |
2022 | Sector Update: Health Care Stocks Again Outpacing Other Sectors to the Ups.. |  |
2022 | Sector Update: Health Care |  |
2022 | Sector Update: Health Care Stocks Edge Higher Pre-Bell Thursday |  |
2022 | Sector Update: Health Care |  |
2022 | F-star Therapeutics Shares Soar on Buyout Deal |  |
2022 | Sino Biopharmaceutical Unit to Buy F-star Therapeutics for $161 Million |  |
2022 | InvoX Pharma to Buy F-star Therapeutics in $161 Million Deal |  |
2022 | Sino Biopharmaceutical Adjusts Conversion Price for Convertible Bonds |  |
2022 | Sino Biopharmaceutical Obtains China Approval for Anti-Asthma Injectable Clinical Trial.. |  |
2022 | Sino Biopharmaceutical Limited Announces Approval of Category 1 Innovative Drug TQC2938.. |  |
2022 | SciClone Pharma Hires Former Sino Biopharma Exec as Chief Medical Officer; Shares Slide.. |  |
2022 | Hong Kong Hang Seng Down 0.6% As Tech Rally Stalls |  |
2022 | Sino Biopharmaceutical Limited's Equity Buyback announced on July 27, 2021, has expired.. |  |
2022 | Generon Corporation Ltd. announced that it expects to receive $70 million in funding fr.. |  |
2022 | China Accepts Sino Biopharm's Marketing Application for Cancer Drug |  |
2022 | Sino Biopharm Buys Back $278 Million of Euro-Denominated Bonds |  |
2022 | Sino Biopharmaceutical Submits Application for Marketing of the Category I Anti-Tumor I.. |  |
2022 | Sino Biopharm Repurchases $168 Million of Euro-Denominated Bonds |  |
2022 | Sino Biopharm Unit to Purchase Tumor Inhibitor of Danish Biotech Firm Symphogen |  |
2022 | Hong Kong Stocks Rebound from Near Two-Month Low; Biotech Shares Rally |  |
2022 | Sino Biopharm Repurchases $86.5 Million of Euro-Denominated Bonds |  |
2022 | Sino Biopharmaceutical Signs License Deal for Hepatitis, Diabetes Drugs |  |
2022 | Sino Biopharm Gets Clearance to Start China Clinical Trial of Anti-Tumor Drug |  |
2022 | Sino Biopharmaceutical Limited's Category I Anti-Tumor Innovative Drug "TQB2930" Obtain.. |  |
2022 | Sino Biopharmaceutical Limited Announces Anlotinib Hydrochloride Capsules Obtains Appro.. |  |
2022 | Sino Biopharmaceutical's TQ-B3525 Drug Gets Breakthrough Therapy Drug Designation from .. |  |
2022 | Chinese Drug Regulator Accepts Sino Biopharmaceutical's Respiratory Diseases Injection .. |  |
2022 | Sino Biopharmaceutical Limited Announces Innovative Drug "TQ-B3525" Was Included in the.. |  |
2022 | Sino Biopharmaceutical Limited Announces That Application for Clinical Trial of "TQC293.. |  |
2022 | Sino Biopharm's New Product Launches Propel Profit by 427% in 2021 |  |
2022 | Sino Biopharm Unveils Share Buyback, Boosts Dividend as 2021 Profit Soars 427% |  |
2022 | Hong Kong Hang Seng Index Up 0.2% in Late Rally |  |
2022 | Sino Biopharmaceutical Limited Proposes Final Dividend for the Final Dividend for 2021,.. |  |
2022 | Sino Biopharmaceutical Limited Reports Earnings Results for the Full Year Ended Decembe.. |  |
2022 | Chinese Regulators OK Sino Biopharma's Clinical Trial of Solid Tumor Treatment |  |
2022 | Sino Biopharm Wins Nod to Start China Clinical Trial of Solid Tumor Drug |  |
2022 | Sino Biopharmaceutical Limited Announces Category I Anti-Tumour Innovative Medicine FHN.. |  |
2022 | Sino Biopharma Partners With Shenzhen XtalPi for Anti-Tumor Drug Development |  |
2022 | Sino Biopharm's Drug for Overactive Bladder Wins Registration Approval in China; Shares.. |  |
2022 | Sino Biopharmaceutical Limited Announces Mirabegron Sustained-Release Tablets Obtained .. |  |
2022 | Sino Biopharm Sees Up to Fivefold Increase in 2021 Profit; Shares Jump 7% |  |
2022 | Sino Biopharm's Antibiotic Wins Marketing Approval, Generic Status in China; Shares Ris.. |  |
2022 | Sino Biopharmaceutical Limited Announces Linezolid Tablets Obtained Drug Registration C.. |  |
2022 | Sino Biopharmaceutical Limited Provides Group Earnings Guidance for the Year Ended 31 D.. |  |
2022 | US FDA OKs Sino Biopharma's Abbreviated NDA for Blood Lipid-Lowering Drug |  |
2022 | Sino Biopharmaceutical Limited Announces Colesevelam Hydrochloride Tablets Obtained AND.. |  |
2022 | China Approves Market Launch of Sino Biopharm's Antipsychotic Medication |  |
2022 | Sino Biopharmaceutical Limited's Lurasidone Hydrochloride Tablets Obtains Drug Registra.. |  |
2022 | Japanese Regulators Allow Sino Biopharma to Sell Anti-Rheumatic Drug |  |
2022 | Sino Biopharma Arm Partners With Biocytogen Pharmaceuticals for Antibody Drugs Developm.. |  |
2022 | Chinese Regulators Grant Drug Registration Certificate to Sino Bio's Generic Rheumatoid.. |  |
2022 | Chinese Regulators Grant Drug Registration Certificates to Sino Bio's Generic Diabetes .. |  |
2022 | Sino Biopharmaceutical Limited Announces Sitagliptin Phosphate Tablet |  |
2022 | Sino Biopharmaceutical Limited Obtains Drug Registration Certificate |  |
2022 | Sino Biopharm Wins Greenlight to Start China Clinical Trial of Pneumoconiosis Treatment.. |  |